Literature DB >> 25895570

Combined approach in the treatment of chronic anal fissures.

S Vershenya1, J Klotz, A Joos, D Bussen, A Herold.   

Abstract

This study was designed to evaluate the healing and complications rates in surgically and conservatively treated patients with chronic anal fissure. Conservative treatment consisted of nitrate or diltiazem ointment. In case of surgery, fissurectomy was performed. In total, 340 patients were included in the study. Among them, 162 patients had surgery and 178 patients had conservative treatment. The healing rate at surgically treated group of patients varied between 95 and 98% depending on previous treatment. Group treated with nitrate ointment and group treated with diltiazem ointment showed, respectively 62% and 52% healing rates. Difference between ointments was not statistically significant. Average healing time was between 105 and 123 days and complication rates were between 1.7 and 5.4%. The surgical treatment showed much higher healing rates and thus should recommended as primary treatment option for the chronic anal fissure, especially if there are chronic secondary lesions already present. In case of conservative treatment, either nitrate or diltiazem ointment could be used with similar efficacy.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25895570     DOI: 10.1007/s13304-015-0290-7

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  54 in total

1.  Randomised trial of topical 0.2% glyceryl trinitrate and lateral internal sphincterotomy for the treatment of patients with chronic anal fissure: long-term follow-up.

Authors:  Gabor Libertiny; John S Knight; Ridzuan Farouk
Journal:  Eur J Surg       Date:  2002

2.  ANAL SPHINCTERIC PRESSURE IN FISSURE IN ANO.

Authors:  H L DUTHIE; R C BENNETT
Journal:  Surg Gynecol Obstet       Date:  1964-07

3.  Effect of isosorbide dinitrate ointment on anal fissure.

Authors:  I Songun; H Boutkan; J B V M Delemarre; P J Breslau
Journal:  Dig Surg       Date:  2003       Impact factor: 2.588

4.  Sequelae of internal sphincterotomy for chronic fissure in ano.

Authors:  I T Khubchandani; J F Reed
Journal:  Br J Surg       Date:  1989-05       Impact factor: 6.939

5.  A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure.

Authors:  G Brisinda; G Maria; A R Bentivoglio; E Cassetta; D Gui; A Albanese
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

6.  A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure.

Authors:  J N Lund; J H Scholefield
Journal:  Lancet       Date:  1997-01-04       Impact factor: 79.321

7.  Randomized clinical trial assessing the side-effects of glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure.

Authors:  H M Kocher; M Steward; A J M Leather; P T Cullen
Journal:  Br J Surg       Date:  2002-04       Impact factor: 6.939

8.  Fissurectomy-botulinum toxin: a novel sphincter-sparing procedure for medically resistant chronic anal fissure.

Authors:  Ian Lindsey; Chris Cunningham; Oliver M Jones; Chris Francis; Neil J McC Mortensen
Journal:  Dis Colon Rectum       Date:  2004-11       Impact factor: 4.585

9.  Topical diltiazem and bethanechol decrease anal sphincter pressure without side effects.

Authors:  E A Carapeti; M A Kamm; B K Evans; R K Phillips
Journal:  Gut       Date:  1999-11       Impact factor: 23.059

10.  Surgical correction of chronic anal fissure: results of lateral internal sphincterotomy vs. fissurectomy--midline sphincterotomy.

Authors:  H Abcarian
Journal:  Dis Colon Rectum       Date:  1980 Jan-Feb       Impact factor: 4.585

View more
  1 in total

1.  Anocutaneous advancement flap provides a quicker cure than fissurectomy in surgical treatment for chronic anal fissure-a retrospective, observational study.

Authors:  Edgar Hancke; Katrin Suchan; Knut Voelke
Journal:  Langenbecks Arch Surg       Date:  2021-06-22       Impact factor: 3.445

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.